Guindi, Maha

Publishing since 1995 (Senior)

Has published 29 publications in 16 years

Number of publications published per year by Guindi, Maha. (Source : PubMed)

Distribution of publications types for Guindi, Maha. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Milot L, Guindi M, Gallinger S, Moulton CA, Brock KK, Dawson LA, Haider MA. MR imaging correlates of intratumoral tissue types within colorectal liver metastases: a high-spatial-resolution fresh ex vivo radiologic-pathologic correlation study.  Radiology  2010;254;3  
•  Chen L, Borozan I, Sun J, Guindi M, Fischer S, Feld J, Anand N, Heathcote J, Edwards AM, McGilvray ID. Cell-type specific gene expression signature in liver underlies response to interferon therapy in chronic hepatitis C infection.  Gastroenterology  2010;138;3  
•  Adeyi O, Fischer SE, Guindi M. Liver allograft pathology: approach to interpretation of needle biopsies with clinicopathological correlation.  J. Clin. Pathol.  2010;63;1  
•  Madill J, Arendt BM, Aghdassi E, Therapondos G, Lilly L, Chow CW, Guindi M, Allard JP. Hepatic lipid peroxidation and antioxidant micronutrients in hepatitis virus C liver recipients with and without disease recurrence.  Transplant. Proc.  2009;41;9  
•  Sandroussi C, Dawson LA, Lee M, Guindi M, Fischer S, Ghanekar A, Cattral MS, McGilvray ID, Levy GA, Renner E, Greig PD, Grant D. Radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma.  Transpl. Int.  2009  
•  Jhaveri KS, Halankar J, Aguirre D, Haider M, Lockwood G, Guindi M, Fischer S. Intrahepatic bile duct dilatation due to liver metastases from colorectal carcinoma.  AJR Am J Roentgenol  2009;193;3  
•  Yap J, O'Connor C, Kirby M, Guindi M, Roberts EA. Sequential antiviral and iron chelation treatment in a teenage boy with congenital anemia, chronic hepatitis C, and secondary hemosiderosis.  J. Pediatr. Gastroenterol. Nutr.  2009;48;3  
•  Bhat M, Guindi M, Heathcote EJ, Hirschfield GM. Transient development of anti-mitochondrial antibodies accompanies autoimmune hepatitis-sclerosing cholangitis overlap.  Gut  2009;58;1  
•  Selzner N, Girgrah N, Lilly L, Guindi M, Selzner M, Therapondos G, Adeyi O, McGilvray I, Cattral M, Greig PD, Grant D, Levy G, Renner EL. The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age.  Liver Transpl.  2008;14;12  
•  O'Brien C, Joshi S, Feld JJ, Guindi M, Dienes HP, Heathcote EJ. Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis.  Hepatology  2008;48;2  

[ See timeline ] [ See all publications ]